Risk Of Developing Liver Cancer After HCV Treatment

Wednesday, October 5, 2016

Hepatitis C drugs now effective for most genotypes

Hepatitis C drugs now effective for most genotypes
Irish Medical Times
October 5, 2016 by

Access to hepatitis C treatment remains an important issue, Gary Culliton reports in his latest Clinical Update. There is currently a significant number of patients who are not eligible for direct-acting antivirals

There are two or three options for the treatment of genotypes one and four. Currently, one treatment is preferred for genotype 3 (sofosbuvir and daclatasvir are used — with or without ribavirin depending on whether the patient has cirrhosis). Newer agents held out the prospect of further options, said Dr Feeney.

Currently all treatments — depending on the genotype — are combinations of two or three antivirals


No comments:

Post a Comment